SpringerProtocols: Abstract: Method for Purification of Human Hematopoietic Stem Cells by Flow Cytometry

Method for Purification of Human Hematopoietic Stem Cells by Flow Cytometry

By: Michael J. Reitsma³, Brenda R. Lee⁴, Nobuko Uchida³

Abstract

Full Text

Download PDF (157K)

Human hematopoietic stem cells (HSCs) and progenitors can be isolated by enriching for a rare cell population with a combination of monoclonal antibodies (MAbs). Such an isolation scheme involves multi-step procedures including ficoll-density fractionation and presort enrichment followed by cell sorting. Over the past decade, various cell-surface and metabolic markers have been identified and used to isolate human HSCs and progenitors as summarized in Table 1. Among them, CD34 has become the most critical cell-surface marker for positively selecting a rare cell population (1,2). Within the CD34⁺ cell population, the differential expression of Thy-1, CD38, and AC133 have been used to fractionate HSCs and progenitors. In order to subfractionate CD34⁺ cells by these markers, the cells can be further purified by flow cytometry. HSCs can be further enriched into a Thy-1⁺ (3–7), CD38^-lo (8–10), Thy-1+ CD38^-lo (11), or AC133+ (12,13) fraction of CD34⁺ cells.

Table 1
Commercially Available Cell-Surface and Metabolic Markers for Isolation of Human HSC and Progenitor Cells
Marker	Expression/Remark	Fluorochrome conjugate recommended	Reference
Positive marker
CD34	Positive	FITC, PE, APC, BIO	1,2,33
Thy-1	Positive	PE, BIO	3,4
AC133	Positive	PE	12,34
Negative/low marker
CD38	Negative /low	FITC, PE, APC	8,9
HLA-DR^a	Negative to low	FITC, PE	35,36
Mature lineage marker, Lin-
CD2	T-cell lineage	FITC, PE, BIO	3
CD3	T-cell lineage	FITC, PE, APC, BIO	3
CD19	B-cell lineage	FITC, PE, APC, BIO	3
CD16	NK-cell lineage	FITC, PE, APC, BIO	3
CD14	Myeloid lineage	FITC, PE	3
CD15	Myeloid lineage	FITC, PE	3
Glycophorin A	Erythroid lineage	FITC, PE	3
2nd Step reagent
Avidin/Streptavidin	For BIO MAb	FITC, PE, APC, TXRD, PharRed, Cy-chrome^d
Metabolic marker^b
Rhodamine 123^c	Low	Mitochondria-binding dye	37,38
Hoechst 33342^c	Low	DNA-binding dye	39,40
Pyronin Y	Low	RNA-binding dye	39,40
Propidium iodide	Negative to low	Dead-cell exclusion
Abbreviations: FBM, fetal bone marrow; MPB, mobilized peripheral blood; ABM, adult bone marrow; HSC, hematopoietic stem cells; FITC, fluorescein; PE, phycoerythrin; APC, allophycocyanin; TXRD, Texas red; BIO, biotinylated. ^a FBM, MPB HSCs express HLA-DR (41,42). ^b To isolate quiescent HSC. ^c Substrates for p-glycoprotein, encoded by MDR-1. HSC possess high levels of p-glycoprotein efflux activity. ^d Recommended for single laser flow cytometry only, lineage marker positive and PI positive cells can be excluded simultaneously.

Affiliation(s): (3) StemCells Inc., Sunnyvale, CA
(4) SyStemix, Inc., Palo Alto, CA

Book Title: Hematopoietic Stem Cell Protocols

Series: Methods in Molecular Medicine | Volume: 63 | Pub. Date: Dec-16-2001 | Page Range: 59-77 | DOI: 10.1385/1-59259-140-X:059

Subject: Cell Biology

References

Download References

1.	Strauss, L. C., Rowley, S. D., La Russa, V. F., Sharkis, S. J., Stuart, R. K., and Civin, C. I., (1986) Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells. Exp. Hematol. 14, 878–886.

2.	Civin, C. I., Strauss, L. C., Brovall, C., Fackler, M. J., Schwartz, J. F., and J. H. Shaper. (1984) Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol. 133, 157–165.

3.	Baum, C. M., Weissman, I. L., Tsukamoto, A. S., Buckle, A. M., and Peault, B. (1992) Isolation of a candidate human hematopoietic stem-cell population. Proc. Natl. Acad. Sci. USA. 89, 2804–2808.

4.	Craig, W., Kay, R., Cutler, R. L., and Lansdorp, P. M. (1993) Expression of Thy-1 on human hematopoietic progenitor cells. J. Exp. Med. 177, 1331–1342.

5.	Murray, L., Chen, B., Galy, A., Chen, S., Tushinski, R., Uchida, N., et al. (1995) Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin-subpopulation from mobilized peripheral blood. Blood 85, 368–378.

6.	Humeau, L., Bardin, F., Maroc, C., Alario, T., Galindo, R., Mannoni, P., et al. (1996) Phenotypic, molecular, and functional characterization of human peripheral blood CD34+/THY1+ cells. Blood 87, 949–955.

7.	Cashman, J. D., Lapidot, T., Wang, J. C., Doedens, M., Shultz, L. D., Lansdorp, P., et al. (1997) Kinetic evidence of the regeneration of multilineage hematopoie-sis from primitive cells in normal human bone marrow transplanted into immuno-deficient mice. Blood 89, 4307–4316.

8.	Terstappen, L. W., Huang, S., Safford, M., Lansdorp, P. M,. and Loken, M. R. (1991) Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34⁺CD38-progenitor cells. Blood 77, 1218–1227.

9.	Petzer, A. L., Zandstra, P. W., Piret, J. M., and Eaves, C. J. (1996) Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J. Exp. Med. 183, 2551–2558.

10.	Prosper, F., Stroncek, D., and Verfaillie, C.M. (1996) Phenotypic and functional characterization of long-term culture-initiating cells present in peripheral blood progenitor collections of normal donors treated with granulocyte colony-stimulating factor. Blood 88, 2033–2042.

11.	Uchida, N., Sutton, R. E., Friera, A. M., He, D., Reitsma, M. J., Chang, W. C., et al. (1998) HIV, but not murine leukemia virus vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95, 11,939–11,944.

12.	Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., et al. (1997) AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90, 5002–5012.

13.	de Wynter, E. A., Buck, D., Hart, C., Heywood, R., Coutinho, L. H., Clayton, A., et al. (1998) CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16, 387–396.

14.	Brugger, W., Henschler, R., Heimfeld, S., Berenson, R. J., Mertelsmann, R., and Kanz, L. (1994) Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 84, 1421–1426.

15.	Gorin, N. C., Lopez, M., Laporte, J. P., Quittet, P., Lesage, S., Lemoine, F., et al. (1995) Preparation and successful engraftment of purified CD34+ bone marrow progenitor cells in patients with non-Hodgkin’s lymphoma. Blood 85, 1647–1654.

16.	Cottler-Fox, M., Cipolone, K., Yu, M., Berenson, R., O’Shaughnessy, J., and Dunbar, C. (1995) Positive selection of CD34+ hematopoietic cells using an immunoaffinity column results in T cell-depletion equivalent to elutriation. Exp. Hematol. 23, 320–322.

17.	Bensinger, W. I., Buckner, C. D., Shannon-Dorcy, K., Rowley, S., Appelbaum, F. R., Benyunes, M., et al. (1996) Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy. Blood 88, 4132–4138.

18.	Civin, C. I., T. Trischmann, N. S. Kadan, J. Davis, S. Noga, Cohen, K., et al. (1996) Highly purified CD34-positive cells reconstitute hematopoiesis. J. Clin. Oncol. 14, 2224–2233.

19.	Handgretinger, R., Lang, P., Schumm, M., Taylor, G., Neu, S., Koscielnak, E., et al. 1998. Isolation and transplantation of autologous peripheral CD34+ progenitor cells highly purified by magnetic-activated cell sorting. Bone Marrow Transplant. 21, 987–993.

20.	Archimbaud, E., Philip, I., Coiffier, B., Michallet, M., Salles, G., Sebban, C., et al. 1997. Selected autologous peripheral blood CD34+Thy-1+Lin-hematopoietic stem cell (HSC) transplantation in multiple myeloma: a European study. Blood. 90(Suppl. 1), 394(Abstract).

21.	Negrin, R., Tierney, K., Stockerl-Goldstein, E., Hu, W., Shizuru, J., Johnston, L., et al. (1997) Rapid hematopoietic engraftment following transplantation of purified CD34+Thy1+ stem cells in patients with metastatic breast cancer. Blood 90(Suppl. 1), 593a(Abstract).

22.	Morrison, S. J. and Weissman, I. L. (1994) The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1, 661–673.

23.	Larochelle, A., Vormoor, J., Hanenberg, H., Wang, J. C., Bhatia, M., Lapidot, T., et al. (1996) Identification of primitive human hematopoietic cells capable of re-populating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2, 1329–1337.

24.	Conneally, E., Cashman, J., Petzer, A., and Eaves, C. (1997) Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. USA 94, 9836–9841.

25.	Punzel, M., Wissink, S. D., Miller, J. S., Moore, K. A., Lemischka, I. R., and Verfaillie, C. M. (1999) The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro. Blood 93, 3750–3756.

26.	Morrison, S. J., Wandycz, A. M., Hemmati, H. D., Wright, D. E., and Weissman, I. L. (1997) Identification of a lineage of multipotent hematopoietic progenitors. Development 124, 1929–1939.

27.	Galy, A., Travis, M., Cen, D., and Chen, B. (1995) Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. Immunity 3, 459–473.

28.	Kondo, M., Weissman, I., and Akashi, K. 1997. Identification of clonogenic common lymphoid prognitor in mouse bone marrow. Cell 91, 661–672.

29.	Keeney, M., Chin-Yee, I., Weir, K., Popma, J., Nayar, R., and Sutherland, D. R. (1998) Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering. Cytometry 34, 61–70.

30.	Wunder, E., Sovalat, H., Henon, P., and Serke, S. (1994) Hematopoietic Stem Cells: The Mulhouse Manual (Serke, S., ed.), AlphaMed Press, Dayton, OH, p. 125.

31.	Robinson, J. P., Darzynkiewicz, Z., Dean, P. N., Orfao, A., Rabinovitch, P. S., Stewart, C. C., et al. (1997) Current Protocol in Cytometry, in Current Protocol in Cytometry, John Wiley & Sons, New York, NY.

32.	Nieto, Y. and Shpall, E. J. (1998) CD34+ blood stem cell transplantation, in Blood stem cell transplantation (Reiffers, J., Goldman, J. M., and Armitage, J. O., eds.) Mosby, St. Louis, MO, pp 187–200.

33.	Andrews, R. G., Singer, J. W., and Bernstein, I. D. (1986) Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67, 842–845.

34.	Miraglia, S., Godfrey, W., Yin, A. H., Atkins, K., Warnke, R., Holden, J. T., et al. (1997) A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 90, 5013–5021.

35.	Srour, E. F., Brandt, J. E., Leemhuis, T., Ballas, C. B., and Hoffman R. (1992) Relationship between cytokine-dependent cell cycle progression and MHC class II antigen expression by human CD34+ HLA-DR-bone marrow cells. J. Immunol. 148, 815–820.

36.	Brandt, J., Briddell, R. A., Srour, E. F., Leemhuis, T. B., and Hoffman, R. (1992). Role of c-kit ligand in the expansion of human hematopoietic progenitor cells. Blood 79, 634–641.

37.	Udomsakdi, C., Eaves, C., Sutherland, H., and Lansdorp, P. (1991) Separation of functionally distinct subpopulations of primitive human hematopoietic cells using rhodamine-123. Exp. Hematol. 19, 338–342.

38.	Uchida, N., Combs, J., Chen, S., Zanjani, E., Hoffman, R., and Tsukamoto, A. (1996) Primitive human hematopoietic cells displaying differential efflux of the rhodamine 123 dye have distinct biological activities. Blood 88, 1297–1305.

39.	Ladd, A. C., Pyatt, R., Gothot, A., Rice, S., McMahel, J., Traycoff, C. M., et al. (1997) Orderly process of sequential cytokine stimulation is required for activation and maximal proliferation of primitive human bone marrow CD34+ hematopoietic progenitor cells residing in G0. Blood 9, 658–668.

40.	Gothot, A., Pyatt, R., McMahel, J., Rice, S., and Srour, E. F. (1997) Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. Blood 90, 4384–4393.

41.	Tsukamoto, A., Weissman, I., Chen, B., DiGiusto, D., Baum, C., Hoffman, R., et al. (1995) Phenotypic and functional analysis of hematopoietic stem cells in mouse and human, in Hematopoietic Stem Cells: Biology and Therapeutic Applications (Levitt, D. and Mertelsmann, R. eds.), pp 85–124.

42.	Waller, E. K., Huang, S., and Terstappen, L. (1995) Changes in the growth properties of CD34+, CD38-bone marrow progenitors during human fetal development. Blood 86, 710–718.

43.	Sasaki, D. T., Tichenor, E. H., Lopez, F., Combs, J., Uchida, N., Smith, C. R., et al. (1995) Development of a clinically applicable high-speed flow cytometer for the isolation of transplantable human hematopoietic stem cells. J. Hematother. 4, 503–514.

44.	Rehse, M. A., Corpuz, S., Heimfeld, S., Minie, M., and Yachimiak, D. (1995) Use of fluorescence threshold triggering and high-speed flow cytometry for rare event detection. Cytometry 22, 317–322.

45.	Van Dilla, M. A., Dean, P. N., Laerum, O. D., and Melamed, M.R. (1985) Flow cytometry: Instrumentation and data analysis, Academic Press, New York, NY.

46.	Merrill, J. T. (1981) Evaluation of selected aerosol-control measures on flow sorters. Cytometry 1, 342–345.

47.	Schmid, I., Nicholson, J. K., Giorgi, J. V., Janossy, G., Kunkl, A., Lopez, P.A., et al. (1997) Biosafety guidelines for sorting of unfixed cells. Cytometry 28, 99–117.

Comments (Loading...)

Post comment/View all comments